Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs
Open Access
- 25 July 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (15) , 10681-10693
Abstract
New chemical modalities in drug discovery include molecules belonging to the bRo5 chemical space. Because of their complex and flexible structure, bRo5 compounds often suffer from a poor solubility/permeability profile. Chameleonicity describes the capacity of a molecule to adapt to the environment through conformational changes; the design of molecular chameleons is a medicinal chemistry strategy simultaneously optimizing solubility and permeability. A default method to quantify chameleonicity in early drug discovery is still missing. Here we introduce Chamelogk, an automated, fast, and cheap chromatographic descriptor of chameleonicity. Moreover, we report measurements for 55 Ro5 and bRo5 compounds and validate our method with literature data. Then, selected case studies (macrocycles, nonmacrocyclic compounds, and PROTACs) are used to illustrate the application of Chamelogk in combination with lipophilicity (BRlogD) and polarity (Δ log kwIAM) descriptors. Overall, we show how Chamelogk deserves being included in property-based drug discovery strategies to design oral bioavailable bRo5 compounds.Keywords
Funding Information
- Universit? degli Studi di Torino
This publication has 58 references indexed in Scilit:
- Optimizing Solubility and Permeability of a Biopharmaceutics Classification System (BCS) Class 4 Antibiotic Drug Using Lipophilic Fragments Disturbing the Crystal LatticeJournal of Medicinal Chemistry, 2013
- Lipophilic and electrostatic forces encoded in IAM-HPLC indexes of basic drugs: Their role in membrane partition and their relationships with BBB passage dataEuropean Journal of Pharmaceutical Sciences, 2012
- The Solubility–Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble DrugsThe AAPS Journal, 2012
- Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical spaceMedChemComm, 2011
- Clinical Pharmacokinetics of EverolimusClinical Pharmacokinetics, 2004
- Pharmacokinetics of Pimecrolimus, a Novel Nonsteroid Anti-Inflammatory Drug, After Single and Multiple Oral AdministrationClinical Pharmacokinetics, 2003
- The Protein Data BankNucleic Acids Research, 2000
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicityJournal of Medicinal Chemistry, 1991
- Molecular dynamics simulations of cyclosporin A: The crystal structure and dynamic modelling of a structure in apolar solution based on NMR dataJournal of Computer-Aided Molecular Design, 1987